Attention-deficit/hyperactivity disorder and risk for drug use disorder: a population-based follow-up and co-relative study

scientific article

Attention-deficit/hyperactivity disorder and risk for drug use disorder: a population-based follow-up and co-relative study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1017/S0033291714001986
P932PMC publication ID4329095
P698PubMed publication ID25119068

P50authorKenneth KendlerQ6390313
P2093author name stringJ Sundquist
H Ohlsson
K Sundquist
P2860cites workExternalizing psychopathology in adulthood: A dimensional-spectrum conceptualization and its implications for DSM-VQ22061884
The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression AnalysisQ22241865
The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey ReplicationQ24632666
Categorical and continuous models of liability to externalizing disorders: a direct comparison in NESARCQ24648322
The worldwide prevalence of ADHD: a systematic review and metaregression analysisQ28304626
Selective drop-out in longitudinal studies and non-biased prediction of behaviour disordersQ33575074
The heritability of clinically diagnosed attention deficit hyperactivity disorder across the lifespanQ33807502
Genetic and environmental influences on behavioral disinhibitionQ33923417
Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion.Q34756508
Twin study of the relationship between adolescent attention-deficit/hyperactivity disorder and adult alcohol dependenceQ35764029
Index of the transmissible common liability to addiction: heritability and prospective associations with substance abuse and related outcomesQ35899209
Childhood ADHD and adolescent substance use: an examination of deviant peer group affiliation as a risk factorQ36838596
Childhood attention deficit hyperactivity disorder and the development of substance use disorders: valid concern or exaggeration?Q37013990
Attention deficit hyperactivity disorder and substance use disordersQ37092722
The boundaries of the internalizing and externalizing genetic spectra in men and womenQ37302715
Linking ADHD, impulsivity, and drug abuse: a neuropsychological perspective.Q37848748
Quantitative and molecular genetics of ADHD.Q37944512
Genetic influences on DSM-III-R drug abuse and dependence: a study of 3,372 twin pairsQ42642168
A Norwegian psychiatric epidemiological studyQ43657292
The structure of common mental disordersQ44243916
The effects of childhood ADHD symptoms on early-onset substance use: a Swedish twin studyQ44366131
Estimating prevalence of problem drug use at national level in countries of the European Union and Norway.Q44373621
Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD.Q44564871
Association between smoking and attention-deficit/hyperactivity disorder symptoms in a population-based sample of young adultsQ44687488
Illicit psychoactive substance use, heavy use, abuse, and dependence in a US population-based sample of male twinsQ44869447
Family transmission and heritability of externalizing disorders: a twin-family studyQ45047376
Prospective effects of attention-deficit/hyperactivity disorder, conduct disorder, and sex on adolescent substance use and abuseQ46972053
Do individuals with ADHD self-medicate with cigarettes and substances of abuse? Results from a controlled family study of ADHD.Q48404312
Stimulant treatment for children: a community perspective.Q50663657
Associations between ADHD and psychoactive substance use disorders. Findings from a longitudinal study of high-risk siblings of ADHD children.Q50919168
Maternal alcohol use disorder and offspring ADHD: disentangling genetic and environmental effects using a children-of-twins design.Q51802589
Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status.Q52035084
Predicting substance use in late adolescence: results from the Ontario Child Health Study follow-upQ52043401
Mental health in first grade and teenage drug, alcohol, and cigarette use.Q52104782
Behavioral disinhibition and the development of substance-use disorders: findings from the Minnesota Twin Family Study.Q52171966
Genetic and environmental influences on behavioral disinhibitionQ56874701
Familial Transmission of Substance Use DisordersQ58564475
Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective follow-up studyQ72990178
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectattention deficit hyperactivity disorderQ181923
substance use disorderQ7632070
attentionQ6501338
P304page(s)977-983
P577publication date2014-08-14
P1433published inPsychological MedicineQ7256364
P1476titleAttention-deficit/hyperactivity disorder and risk for drug use disorder: a population-based follow-up and co-relative study
P478volume45

Reverse relations

cites work (P2860)
Q38665501ADHD Medication and Substance-Related Problems
Q37671741ADHD symptoms in non-treatment seeking young adults: relationship with other forms of impulsivity.
Q50198766Associations between childhood ADHD, gender, and adolescent alcohol and marijuana involvement: A causally informative design
Q45070504Childhood ADHD Symptoms and Future Illicit Drug Use: The Role of Adolescent Cigarette Use.
Q40160938Childhood attention-deficit/hyperactivity disorder symptoms and the development of adolescent alcohol problems: A prospective, population-based study of Swedish twins
Q33859001Common adult psychiatric disorders in Swedish primary care where most mental health patients are treated
Q36801392Cross-generational transmission from drug abuse in parents to attention-deficit/hyperactivity disorder in children
Q40479524Examining the association between attention deficit hyperactivity disorder and substance use disorders: A familial risk analysis.
Q47660024Increased Risk of Smoking in Female Adolescents Who Had Childhood ADHD.
Q36109589Prescription reporting with immediate medication utilization mapping (PRIMUM): development of an alert to improve narcotic prescribing
Q38832013TOP TEN RESEARCH PRIORITIES FOR ATTENTION DEFICIT/HYPERACTIVITY DISORDER TREATMENT.

Search more.